Where Biology Meets Visible Aging: Understanding and Managing Inflamaging

by Dr Dima Maraqa, MD

Dentist, Amman, Jordan

Dr. Dima Maraqa is a dentist and aesthetic practitioner based in Amman, Jordan, specializing in non-surgical facial aesthetics since 2016. She has a strong passion for the science and technology behind every procedure she performs. She believes that true beauty starts with knowledge, precision, and evidence-based techniques. Her approach focuses on achieving natural, safe, and long-lasting results for every patient.

Introduction

Inflamaging — a term derived from “inflammation” and “aging” — describes the persistent, low-grade inflammatory state that develops subtly with age. Unlike acute inflammation, which protects the body, inflamaging is chronic, silent, and cumulative, affecting both internal tissues and the skin. At the cellular and molecular levels, senescent cells, mitochondrial dysfunction, oxidative stress, and immunosenescence create a network of inflammatory signals that gradually compromise tissue integrity. This ongoing process not only accelerates structural aging internally but also manifests externally as fine lines, laxity, pigmentation irregularities, dullness, and slower tissue regeneration. Understanding these mechanisms provides clinicians and aesthetic practitioners with a roadmap to address aging at its biological roots — where biology truly meets visible aging [1,2].

Cellular and Molecular Pathways of Aging

Aging at the cellular level involves complex pathways that drive tissue decline and visible signs of aging.

1. Cellular Senescence and SASP
   Senescent cells are aged or stressed cells that have stopped dividing but remain metabolically active. They secrete pro-inflammatory molecules known as the Senescence-Associated Secretory Phenotype (SASP), including IL-6, IL-1β, TNF-α, chemokines, growth factors, and matrix metalloproteinases (MMPs). SASP disrupts neighboring cells, degrades extracellular matrix components, and promotes chronic inflammation in both skin and deeper tissues [3,4].
2. Mitochondrial Dysfunction and Oxidative Stress
   Aging mitochondria produce excessive reactive oxygen species (ROS) and reduced ATP. ROS causes oxidative damage to lipids, DNA, and proteins, activating NF-κB and NLRP3 inflammasome pathways. This creates a feedback loop that perpetuates chronic inflammation and accelerates tissue breakdown [5,6].
3. Immunosenescence
   The aging immune system loses efficiency. Impaired clearance of damaged or senescent cells allows inflammatory signals to persist. This systemic low-grade inflammation manifests in the skin as slow healing, sensitivity, and structural degradation [7].
4. Barrier Dysfunction and Microbiome Changes
   A weakened skin barrier leads to increased transepidermal water loss and greater sensitivity to environmental stressors. Altered skin microbiome composition can further trigger innate immune receptors, amplifying local inflammation [8].
5. Glycation and Protein Cross-Linking
   High glucose and oxidative stress promote non-enzymatic glycation, forming Advanced Glycation End-products (AGEs). Collagen and elastin cross-link, losing elasticity and becoming more susceptible to degradation, further enhancing inflamaging [9].

Clinical Manifestations in Skin

Inflamaging affects both structure and appearance:

• Collagen and elastin breakdown → fine lines, laxity
• Reduced fibroblast function → thin, fragile skin
• Slower keratinocyte turnover → dullness, uneven texture
• Increased melanocyte stimulation → hyperpigmentation
• Impaired microcirculation → tired or pale appearance
• Barrier compromise → dryness, sensitivity, inflammation

These changes often appear before patients notice systemic symptoms, making early recognition essential in aesthetic practice [2,3].

Key Molecular Pathways in Inflamaging

• NF-κB Pathway: Master regulator of inflammation; chronically activated by ROS and SASP, stimulates cytokines and MMPs.
• NLRP3 Inflammasome: Triggers IL-1β and IL-18, amplifying inflammation.
• mTOR Pathway: Controls cell growth and metabolism; overactivation accelerates senescence.
• AMPK Pathway: Anti-inflammatory and energy-balancing; declines with age.
• Sirtuin (SIRT) Pathways: Longevity regulators supporting DNA repair and antioxidant defense; reduced activity weakens resilience [4,6].

Clinical Assessment and Monitoring

1. History & Lifestyle Assessment
   • Sleep, diet, stress, exercise, UV exposure, smoking, alcohol, gut health.
2. Laboratory Screening
   • hs-CRP, fasting glucose/insulin, HbA1c, cytokine panels (optional).
   • Vitamin D, antioxidant status, ferritin (contextual).
3. Skin Assessment
   • High-resolution photography for monitoring
   • Barrier evaluation: dryness, TEWL if equipment available
   • Healing time and reaction post-procedure

Early identification allows practitioners to tailor aesthetic protocols and adjunctive systemic support.

Strategies to Reduce and Prevent Inflamaging

• Topical Approaches
• Retinoids: boost turnover, reduce senescence
• Niacinamide: barrier support, reduce inflammation
• Antioxidants: vitamin C/E, ferulic acid, CoQ10
• Peptides: support collagen and cellular communication
• Lifestyle & Nutritional Support
• Omega-3 fatty acids, polyphenols, low-glycemic diet
• Sleep optimization, stress management, regular moderate exercise
• Professional Interventions
• Microneedling, bio-stimulators, PRP/PRF, non-ablative laser
• Gentle, staged protocols to avoid barrier disruption and inflammation
• Combining internal health support with carefully selected procedures maximizes aesthetic outcomes and reduces adverse events [1,5,7].

References

1. Franceschi C, Garagnani P, Parini P, Giuliani C, Santoro A. Inflammaging: a new immune–metabolic viewpoint for age-related diseases. Nat Rev Endocrinol. 2018;14:576–590.
2. López-Otín C, Blasco MA, Partridge L, Serrano M, Kroemer G. The hallmarks of aging. Cell. 2013;153:1194–1217.
3. Freund A, Orjalo AV, Desprez PY, Campisi J. Inflammatory networks during cellular senescence: causes and consequences. Trends Mol Med. 2010;16:238–246.
4. Ziegler F, Tchkonia T, Kirkland JL. Cellular senescence: mechanisms and therapeutic opportunities. J Clin Invest. 2021;131:e148850.
5. Birch J, Gil J. Senescence and the SASP: many therapeutic avenues. Nat Cell Biol. 2020;22:1040–1050.
6. Tchkonia T, Zhu Y, van Deursen J, Campisi J, Kirkland JL. Cellular senescence and the senescent secretory phenotype: therapeutic opportunities. J Clin Invest. 2013;123:966–972.
7. Ganesan A, et al. Oxidative stress in skin aging. Dermato-Endocrinology. 2018;10:e1430918.
8. Sanford JA, Gallo RL. Functions of the skin microbiota in health and disease. Semin Immunol. 2013;25:370–377.
9. Monnier VM, Sell DR. The biology of aging and protein glycation. Ann N Y Acad Sci. 2012;1259:1–13.